Picture of Silence Therapeutics logo

SLN — Silence Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Silence Therapeutics PLC Says Cash And Cash Equivalents Of £73.5 Mln Is Sufficient To Fund Operations Through Early 2023

March 17 (Reuters) - Silence Therapeutics PLC  SLNCF.PK :
    * SILENCE THERAPEUTICS PLC - BELIEVES CASH AND CASH
EQUIVALENTS OF
£73.5 MILLION AS OF END OF DEC 2021 IS SUFFICIENT TO FUND
OPERATIONS THROUGH EARLY 2023

Source text for Eikon:  ID:nBw4x9P9pa 
Further company coverage:  SLNCF.PK

Recent news on Silence Therapeutics

See all news